PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 368.00
Bid: 366.00
Ask: 371.00
Change: 6.00 (1.66%)
Spread: 5.00 (1.366%)
Open: 369.00
High: 370.00
Low: 365.00
Prev. Close: 362.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Bank of Cyprus Holdings PLC

2 Sep 2022 14:18

RNS Number : 1520Y
European Bank for Recon & Develop
02 September 2022
 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

European Bank for Reconstruction and Development

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

NA

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Bank of Cyprus Holding Plc (Offeree)

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

NA

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

02/09/2022

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

Ordinary Shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

22,401,744

5.021%

(2) Cash-settled derivatives

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

Total

22,401,744

5.021%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 None

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

NO

 

Date of disclosure

02/09/2022

Contact name

Tamas Nagy, Director, Co-head Private Equity

Telephone number

+44 207 338 6628

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

Ap31

 

NOTES ON FORM 8.3

 

1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. See Rule 2.5(d) of Part A of the Rules.

 

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEBKBBDNBKDOCK
Date   Source Headline
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20219:13 amRNSTR-1 Notification - Caius
1st Sep 20218:39 amRNSDoc re. (1H2021 Investor Presentation)
1st Sep 20217:27 amRNSHalf-year Report -4
1st Sep 20217:20 amRNSHalf-year Report -3
1st Sep 20217:03 amRNSHalf-year Report -2
1st Sep 20217:02 amRNSDoc re. (1H2021 Investor Presentation)
1st Sep 20217:00 amRNS1H2021 Group Financial Results
1st Sep 20217:00 amRNSHalf-year Report -1
20th Aug 20218:53 amRNSDate of announcement of 1H2021 FR
23rd Jul 202110:55 amRNSRenewal of collective agreement
28th Jun 202111:24 amRNSCompletion of Project Helix 2 (Portfolios A and B)
23rd Jun 20219:38 amRNSDirector/PDMR Shareholding- Iordanou
16th Jun 20214:23 pmRNSIssue of Debt
16th Jun 20218:14 amRNSTR-1 Notification - Carval
9th Jun 202110:03 amRNSDirector/PDMR Shareholding
8th Jun 202110:14 amRNSDirector/PDMR Shareholding- Iordanou
4th Jun 202110:04 amRNSDirector/PDMR Shareholding- Iordanou
3rd Jun 20211:34 pmRNSDirector/PDMR Shareholding - Iordanou
2nd Jun 20218:35 amRNSDirector/PDMR Shareholding- Mr. Iordanou
2nd Jun 20218:32 amRNSDirector/PDMR Shareholding- Mr. Iordanou
2nd Jun 20218:31 amRNSDirector/PDMR Shareholding- Mr. Iordanou
1st Jun 20217:00 amRNSPDMR Notification of Transaction - Iordanou
28th May 20212:07 pmRNSAnnouncement
25th May 202112:34 pmRNSResult of AGM
25th May 20217:02 amRNSDoc re. (1Q2021 Investor Presentation)
25th May 20217:00 amRNS1Q2021 Group Financial Results
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20217:09 amRNSDate of announcement of 1Q2021 FR
29th Apr 20214:40 pmRNSSecond Price Monitoring Extn
29th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Apr 202110:17 amRNSNotice of AGM
21st Apr 202110:54 amRNSResults of Cash Tender Offer
20th Apr 20212:23 pmRNSIssue of Tier 2 Capital Notes - Replacement
16th Apr 20216:01 pmRNSIssue of Tier 2 Capital Notes
7th Apr 20211:18 pmRNSPillar 3 Disclosures 2020
7th Apr 202111:30 amRNSTR-1 Notification - Carval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.